Overview
Dr. Kinderwood's Asylum invites players into a world teetering on the brink of collapse. An epidemic of flower disease has ravaged a once-prosperous village, leaving only the son of a tailor and a witch doctor as a survivor. With the disease's symptoms manifesting and all other avenues closed, the young man finds his only refuge in a peculiar, fading estate. This estate is presided over by an unsociable owner who wears a sinister mask, and it shelters a cast of unusual guests, including a circus acrobat, two highway thugs, and a noble knight with his arrogant young master. All share a common thread: they are living out their final days.
Highlights
- Genre Blend: This title combines elements of Adventure, Indie, and RPG genres, offering a rich narrative experience.
- Narrative Focus: With a strong emphasis on story and choices that matter, players can expect a nonlinear journey with multiple endings.
- Early Access: Developed and published by Richday, Dr. Kinderwood's Asylum is slated for release soon, with players encouraged to wishlist it for updates.
Who It's For
Fans of visual novels, interactive fiction, and story-rich RPGs will find themselves drawn to Dr. Kinderwood's Asylum. Players who enjoy games where their decisions have significant consequences and who appreciate exploring dark, mysterious narratives with multiple branching paths will particularly connect with this experience. The game also features content descriptors for human or animal organs, blood, and violent mutilation, indicating a mature thematic focus.
Game Info
Dr. Kinderwood's Asylum is a single-player experience developed and published by Richday. It supports a wide range of languages, including English, French, Italian, German, Spanish, Portuguese, Simplified Chinese, Korean, Russian, Turkish, and Japanese. While it offers partial controller support, its core gameplay appears to be rooted in narrative progression and player choice, typical of the visual novel and RPG genres it encompasses. The game is marked as a paid title, and its release is anticipated soon.





